Thus, our nanoString screen suggests that in renal tumors from subjects with obesity, increases in CD36 and IDO1, with concomitant decreases in T cell-related CD7 and CCL21, are consistent with a host environment that favors tumor progression. The gene discussed is IDO1; the disease is obesity disorder.